» Articles » PMID: 2783251

Recombinant and Native Human Urinary Colony-stimulating Factor Directly Augments Granulocytic and Granulocyte-macrophage Colony-stimulating Factor Production of Human Peripheral Blood Monocytes

Overview
Journal Exp Hematol
Specialty Hematology
Date 1989 Jan 1
PMID 2783251
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Colony-stimulating factor from human urine (CSF-HU) has been purified to a homogeneous protein, and its complementary DNA (cDNA) has been cloned. Recombinant CSF-HU was prepared from a serum-free medium conditioned by Chinese hamster ovary cells transfected with the cDNA and purified by the same method as that for the native protein. Purified CSF-HU stimulated human bone marrow cells to form macrophage colonies. It also stimulated human mature monocytes prepared from peripheral blood of healthy volunteers to produce human active colony-stimulating activity that stimulates human bone marrow cells to form granulocyte and macrophage colonies. This activity was partially neutralized by the addition of both polyclonal antibodies against human granulocyte colony-stimulating factor and against human granulocyte-macrophage CSF, respectively. The stimulation of monocytes by CSF-HU was not inhibited by the addition of polymyxin-B, which is known as a potent inhibitor of endotoxin. On the other hand, CSF-HU did not stimulate monocyte production of interleukin-1 and interferon. These results indicate that recombinant and native CSF-HU stimulates immature cells as well as mature cells in the human monocyte lineage.

Citing Articles

Functional alterations of proinflammatory monocytes by T regulatory cells: implications for the prevention and reversal of type 1 diabetes.

Sia C, Hanninen A Rev Diabet Stud. 2010; 7(1):6-14.

PMID: 20703434 PMC: 2923376. DOI: 10.1900/RDS.2010.7.6.


Increased macrophage colony-stimulating factor levels in patients with Graves' disease.

Morishita E, Sekiya A, Hayashi T, Kadohira Y, Maekawa M, Yamazaki M Int J Hematol. 2008; 88(3):272-277.

PMID: 18751872 DOI: 10.1007/s12185-008-0155-7.


Therapeutic efficacy of human macrophage colony-stimulating factor, used alone and in combination with antifungal agents, in mice with systemic Candida albicans infection.

Kuhara T, Uchida K, Yamaguchi H Antimicrob Agents Chemother. 1999; 44(1):19-23.

PMID: 10602717 PMC: 89622. DOI: 10.1128/AAC.44.1.19-23.2000.


Transformation of rat glioma cells with the M-CSF gene inhibits tumorigenesis in vivo.

Yoshioka H, Hama S, Sadatomo T, Taniguchi E, Harada K, Sugiyama K J Neurooncol. 1999; 40(3):197-204.

PMID: 10066091 DOI: 10.1023/a:1006177328576.


Tumoricidal effect of human macrophage-colony-stimulating factor against human-ovarian-carcinoma-bearing athymic mice and its therapeutic effect when combined with cisplatin.

Adachi T, Mano H, Shinohara Y, Nakanishi T, Suzuki T, Ino K Cancer Immunol Immunother. 1993; 37(1):1-6.

PMID: 8513448 PMC: 11038878. DOI: 10.1007/BF01516935.